Dr. ANSHUL GUPTA

• Father's Name: Ashok Gupta
• Date of Birth: 04/03/88

Consultant, Medical Oncology, Max Super Speciality Hospital Vaishali & Noida, 31/01/23

• 1st prize in inter-college Medicine quiz held at University College of Medical Sciences, New Delhi in Dec 2015.
• Youth Mentorship Award’ in 2016 from Maulana Azad Medical College Old Student’s Association (MAMCOS)

• Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Gupta A, Gogia A, Deo S, Sharma DN, Mathur S, Sagiraju HKR. Cancer Treat Res Commun. 2023;36:100741. doi: 10.1016/j.ctarc.2023.100741. Epub 2023 Jul 9. PMID: 37453371.
• A real-world experience of TCH (docetaxel/carboplatin/trastuzumab) regimen in early, locally advanced and oligometastatic HER2 positive breast cancer from tertiary care center in North India, Gupta A, Gogia A, Sagiraju HKR, Deo SVS, Gupta R, Mathur S, et al., J Clin Oncol, 06/02/22, https://ascopubs.org/doi/pdf/10.1200/JCO.2022.40.16_suppl.e12505
• Outcomes of neoadjuvant combination chemotherapy with and without targeted therapy in HER2-positive breast cancer: A real-world experience from tertiary care center in North India, Gupta A, Gogia A, Sagiraju HKR, Deo SVS, Sharma D, Mathur S, et al., J Clin Oncol, 06/02/22, https://ascopubs.org/doi/pdf/10.1200/JCO.2022.40.16_suppl.e12601
• Ribociclib-induced flagellate rash, Gupta A, Gogia A, Cancer Res Stat Treat, 06/01/22, 5, 2, 397–8
• Lenvatinib plus pembrolizumab for advanced endometrial cancer, Gupta A, Gogia A, Cancer Res Stat Treat, 06/01/22, 5, 2, 351
• Systemic therapy in advanced dermatofibrosarcoma protuberans: Imatinib and beyond, Gupta A, Rastogi S, Kumar C S, Barwad A, Dhamija E, Panday R, et al., J Clin Oncol, 05/20/19, 37, 15_suppl, e22523–e22523
• Extra-nasal NK/T-cell lymphoma: A rare case with a rarer presentation, Kumar C, Jain G, Gupta A, Pramanik R, Chopra A, Cytopathology, 07/01/22, 33, 4, 518-521, 10.1111/cyt.13095, 34995382
• Efficacy of low dose pazopanib in advanced soft tissue sarcoma (STS): Experience from a dedicated sarcoma medical oncology clinic in India, Kumar C S, Rastogi S, Prajapati R, Barwad A, Aggarwal A, Gupta A, et al., J Clin Oncol, 05/20/19, 37, 15_suppl, e22555–e22555
• Renal Ewing’s sarcoma: A single institute experience of seven patients, Shishak S, Rastogi S, Panday R, Sharma D, Barwad A, Gupta A, et al., J Clin Oncol, 05/20/19, 37, 15_suppl, e22538–e22538

• Prof. Atul Sharma, Vice-Chairman, Medical Oncology, Hematology & BMT, Max Hospital Saket, atul1@hotmail.com, 9818548149
• Dr S.P. Kataria, Vice-Chairman, Medical Oncology, Medanta Hospital, Gurugram, spkataria@gmail.com, 9868818541
• Prof. Sameer Bakhshi, Director Professor & HOD, Medical Oncology Dept, All India Institute of Medical Sciences, sambakh@hotmail.com, 9958828763
• Dr. Ajay Gogia, Additional Professor, Medical Oncology Dept, All India Institute of Medical Sciences, ajaygogia@gmail.com, 9013000642

• American Society of Clinical Oncology (ASCO)
• European Society of Medical Oncology (ESMO)
• Member, Medical oncology Working Group, Comprehensive Breast Collaborative Society (CBCS)
• Reviewer for Cancer Treatment and Research Communications (Elsevier Publications)
• Indian Society of Medical and Pediatric Oncology
• Indian Association of Palliative Care (IAPC)